Literature DB >> 3008134

Possible relationship of the locus coeruleus--hippocampal noradrenergic neurons to depression and mode of action of antidepressant drugs.

W Kostowski.   

Abstract

Recent studies performed in our laboratory suggest involvement of locus coeruleus (LC) and hippocampal noradrenergic (NE) neurons in the mechanism of depression and mode of action of antidepressants. Both electrolytic and 6-OHDA lesions to the LC abolished desipramine action in forced swim test in rats. The action of desipramine was also reduced in rats pretreated with alpha 1 adrenolytic drugs -- phenoxybenzamine and prazosin. Electrical stimulation of the LC produced, like desipramine, activating effect in forced swim test, the phenomenon never observed in phenoxybenzamine-pretreated animals. Chronic (but not acute) administration of desipramine potentiated activatory effects of intrahippocampal injections of NE and phenylephrine but not isoprenaline in both open field and forced swim test. Depressant effect of intrahippocampal clonidine was reversed by chronic desipramine (in the open field test). The effect of desipramine was partially shared by citalopram.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3008134

Source DB:  PubMed          Journal:  Pol J Pharmacol Pharm        ISSN: 0301-0244


  6 in total

1.  Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression.

Authors:  Rebecca E Horton; Deana M Apple; W Anthony Owens; Nicole L Baganz; Sonia Cano; Nathan C Mitchell; Melissa Vitela; Georgianna G Gould; Wouter Koek; Lynette C Daws
Journal:  J Neurosci       Date:  2013-06-19       Impact factor: 6.167

2.  The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration.

Authors:  Agnieszka Nikiforuk; Tomasz Kos; Anna Wesołowska
Journal:  Psychopharmacology (Berl)       Date:  2011-04-16       Impact factor: 4.530

Review 3.  The role of the central noradrenergic system in behavioral inhibition.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res Rev       Date:  2011-03-05

4.  Evaluation of the antidepressant therapeutic potential of isocyanine and pseudoisocyanine analogues of the organic cation decynium-22.

Authors:  Anwen M Krause-Heuer; Rheaclare Fraser-Spears; Jeremy C Dobrowolski; Mark E Ashford; Naomi A Wyatt; Maxine P Roberts; Georgianna G Gould; Wai-Ching Cheah; Clarissa K L Ng; Mohan Bhadbhade; Bo Zhang; Ivan Greguric; Nial J Wheate; Naresh Kumar; Wouter Koek; Paul D Callaghan; Lynette C Daws; Benjamin H Fraser
Journal:  Eur J Med Chem       Date:  2017-06-07       Impact factor: 6.514

Review 5.  Is the forced swimming test a suitable model for revealing antidepressant activity?

Authors:  F Borsini; A Meli
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.

Authors:  John F Cryan; Olivia F O'Leary; Sung-Ha Jin; Julie C Friedland; Ming Ouyang; Bradford R Hirsch; Michelle E Page; Ashutosh Dalvi; Steven A Thomas; Irwin Lucki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.